Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,428 | -13,905 | -15,508 | -11,728 | -2,174 |
| Depreciation Amortization | 663 | 649 | 649 | 5 | 1 |
| Other Working Capital | -319 | -1,519 | 1,574 | 845 | 111 |
| Other Operating Activity | 4,872 | 852 | 471 | -1,017 | -1,113 |
| Operating Cash Flow | $-15,212 | $-13,923 | $-12,814 | $-11,895 | $-3,174 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 11 | N/A | 75 | -107 | -22 |
| Net Acquisitions | N/A | N/A | N/A | -2,193 | N/A |
| Investing Cash Flow | $11 | $N/A | $75 | $-2,300 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 392 | 0 | N/A |
| Debt Repayment | N/A | N/A | -392 | 0 | N/A |
| Common Stock Issued | 63,967 | 0 | N/A | N/A | 57,237 |
| Common Stock Repurchased | N/A | N/A | -3,726 | -3,206 | N/A |
| Other Financing Activity | -448 | 4,517 | 0 | 0 | -1,307 |
| Financing Cash Flow | $63,519 | $4,518 | $-3,726 | $-3,206 | $55,929 |
| Exchange Rate Effect | 19 | -3 | -4 | 10 | -11 |
| Beginning Cash Position | 6,923 | 16,331 | 33,088 | 52,902 | 244 |
| End Cash Position | 55,260 | 6,923 | 16,331 | 33,088 | 52,967 |
| Net Cash Flow | $48,337 | $-9,408 | $-16,757 | $-19,814 | $52,723 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,212 | -13,923 | -12,814 | -11,895 | -3,174 |
| Capital Expenditure | N/A | N/A | -34 | -107 | -22 |
| Free Cash Flow | -15,212 | -13,923 | -12,848 | -12,002 | -3,196 |